Literature DB >> 4137868

Oestradiol synthesis by a human breast carcinoma.

W R Miller, A P Forrest.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4137868     DOI: 10.1016/s0140-6736(74)91202-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  Interplay of estrogen receptors and FOXA factors in the liver cancer.

Authors:  Yongbing Zhao; Zhaoyu Li
Journal:  Mol Cell Endocrinol       Date:  2015-02-04       Impact factor: 4.102

Review 2.  Recent advances in studies on estrogen biosynthesis.

Authors:  A M Brodie
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

3.  Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.

Authors:  Niramol Chanplakorn; Pongsthorn Chanplakorn; Takashi Suzuki; Katsuhiko Ono; Lin Wang; Monica S M Chan; Loo Wing; Christopher C P Yiu; Louis Wing-Cheong Chow; Hironobu Sasano
Journal:  Horm Cancer       Date:  2011-02       Impact factor: 3.869

4.  Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients.

Authors:  R C Mason; D A Burns; W R Miller; R A Hawkins; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.

Authors:  K J Willis; D R London; H W Ward; W R Butt; S S Lynch; B T Rudd
Journal:  Br Med J       Date:  1977-02-12

6.  [The influence of endogenous hormones on the oestrogen and progesterone receptor determination in tissue of mammary carcinoma (author's transl)].

Authors:  H Caffier; H Brandau
Journal:  Arch Gynakol       Date:  1978-07-19

7.  Aminoglutethimide. Penetration of the blood brain barrier.

Authors:  C Unger; H Eibl; H W von Heyden; D J Kim; G A Nagel
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

8.  Effects of drugs associated with hyperprolactinemia on plasma steroids and on steroid receptors and metabolism in human breast cancer.

Authors:  R C Mason; W R Miller; R A Hawkins; M S Brown; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

9.  Conversion to estriol in "normal", benign and malignant human breast tissues.

Authors:  R Seshadri; N D Bagli-Vania; J N Suraiya; N A Sheth
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

10.  Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial.

Authors:  Matthew J Ellis; William R Miller; Yu Tao; Dean B Evans; Hilary A Chaudri Ross; Yasuhiro Miki; Takashi Suzuki; Hironobu Sasano
Journal:  Breast Cancer Res Treat       Date:  2008-10-22       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.